[{"AdditionalPaidInCapital_0_Q2_USD":5162459.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"Cash_0_Q2_USD":1103112.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":242370.0,"PrepaidExpenseCurrent_0_Q2_USD":242370.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":5600000.0,"SharePrice_0_Q2_USD":10.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-23622.0,"RepaymentsOfRelatedPartyDebt_2_Q2_USD":200000.0,"InvestmentIncomeInterest_2_Q2_USD":121508.0,"InvestmentIncomeInterest_1_Q2_USD":78823.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1103112.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":230000000.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":230121508.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":1078112.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":4090364.0,"SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_0_Q2_shares":22003638.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":220036380.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_1_Q2_USD":-194558.0,"OperatingIncomeLoss_2_Q2_USD":-282332.0,"DeferredTaxAssetsNet_0_Q2_USD":39000.0,"Assets_0_Q2_USD":231466990.0,"AssetsCurrent_0_Q2_USD":1345482.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1100000.0,"CommonStockSharesOutstanding_0_Q2_shares":5750000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":182582.0,"GeneralAndAdministrativeExpense_1_Q2_USD":144508.0,"Liabilities_0_Q2_USD":6430600.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":231466990.0,"LiabilitiesCurrent_0_Q2_USD":130600.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":231509636.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-431524.0,"NetIncomeLoss_2_Q2_USD":-160824.0,"NetIncomeLoss_1_Q2_USD":-115735.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":200000.0,"ProfitLoss_2_Q2_USD":-160824.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-163124.0,"StockholdersEquity_0_Q2_USD":5000010.0,"AccruedLiabilitiesCurrent_0_Q2_USD":13000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-230000000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"Ticker":"TOI","CIK":"1799191","name":"DFP HEALTHCARE ACQUISITIONS CORP.","OfficialName":"The Oncology Institute Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"520068227.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20200813"}]